GlassScriptPhysician profile
Regina Simonetti
NPI 1427163369
$623.59
in general payments reported to CMS, 2019-2025
12 companies · $55.21 in 2025
The $55.21 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $11.41 · 2021: $46.97 · 2022: $58.42 · 2023: $121 · 2024: $220 · 2025: $55.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $168.25 | 2019-2024 | Auvi-Q |
| Sanofi Pasteur INC. | $120.58 | 2021-2025 | |
| Pfizer INC. | $101.21 | 2019-2024 | |
| Alk-Abello, INC | $47.61 | 2024 | Odactra, Ragwitek, Grastek |
| Sobi, INC | $33.60 | 2021-2023 | |
| Adlon Therapeutics L.P. | $29.71 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $29.04 | 2024 | Relexxii |
| Takeda Pharmaceuticals U.S.A., INC. | $26.60 | 2019-2020 | |
| Sanofi US Services INC. | $20.17 | 2024 | |
| Merck Sharp & Dohme LLC | $18.68 | 2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Glaxosmithkline, LLC. | $16.25 | 2024 | Bexsero |
| Tris Pharma INC | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Simonetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.